(19)
(11) EP 1 100 763 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
17.08.2005 Bulletin 2005/33

(45) Mention of the grant of the patent:
22.06.2005 Bulletin 2005/25

(21) Application number: 99934986.3

(22) Date of filing: 27.07.1999
(51) International Patent Classification (IPC)7: C07C 59/76, C07D 207/30, C07D 307/34, C07D 333/04, A61K 31/19, A61K 31/335, A61K 31/40, A61K 31/38
(86) International application number:
PCT/GB1999/002446
(87) International publication number:
WO 2000/006529 (10.02.2000 Gazette 2000/06)

(54)

DIKETOACID-DERIVATIVES AS INHIBITORS OF POLYMERASES

DIKETOSÄURE-DERIVATE ALS HEMMSTOFFE VON POLYMERASEN

DERIVES DE DICETOACIDES UTILISES COMME INHIBITEURS DE POLYMERASES

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 27.07.1998 GB 9816358
13.08.1998 US 96528 P

(43) Date of publication of application:
23.05.2001 Bulletin 2001/21

(73) Proprietor: Instituto di Ricerche di Biologia Molecolare p Angeletti S.P.A.
00040 Pomezia (IT)

(72) Inventors:
  • ALTAMURA, Sergio
    I-00136 Rome (IT)
  • TOMEI, Licia
    I-00143 Rome (IT)
  • KOCH, Uwe
    I-00041 Albano Laziale (IT)
  • NEUNER, Philippe, Jean, Siegfried
    I-00041 Albano Laziale (IT)
  • SUMMA, Vincenzo
    I-00049 Velletri (IT)

(74) Representative: Horgan, James Michael Frederic et al
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR
Harlow, Essex CM20 2QR (GB)


(56) References cited: : 
DE-A- 3 214 082
US-A- 5 475 109
 US-A- 4 337 258
   
  • TOMASSINI ET AL.: "Inhibition of ...." ANTIMICROB. AGENTS CHEMOTHERAP., vol. 38, no. 12, 1994, pages 2827-2837, XP002119719
  • BEILSTEIN INFORMATION SERVICE: FILE: XFIRE, XP002119720
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).